Far East Bio-Tec. Co., Ltd.(TW:6886)
NT$38.650.00 (0.00%)
TW:6886
Far East Bio-Tec. Co., Ltd. financials statements
NT$38.65
At close:0.00 (0.00%)
Far East Bio-Tec. Co., Ltd. (6886) Ratios
Far East Bio-Tec. Co., Ltd. Ratios
TW:6886's free cash flow for Q2 2026 was NT$1.83M. For the 2026 fiscal year, TW:6886's free cash flow was decreased by NT$-7.43M and operating cash flow was NT$9.27M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.88 | 5.16 | 7.32 | 4.67 | 4.96 |
| Quick Ratio | 4.36 | 4.20 | 6.03 | 3.90 | 4.27 |
| Cash Ratio | 3.77 | 3.55 | 5.09 | 3.38 | 3.84 |
| Solvency Ratio | 0.72 | 0.56 | 0.51 | 0.91 | 0.48 |
| Operating Cash Flow Ratio | 0.68 | 0.99 | -0.04 | 1.22 | 0.82 |
| Short-Term Operating Cash Flow Coverage | 4.05 | 4.85 | -0.14 | 5.36 | 3.76 |
| Net Current Asset Value | NT$ 309.80M | NT$ 272.09M | NT$ 352.19M | NT$ 294.65M | NT$ 228.14M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.11 | 0.07 | 0.09 | 0.10 |
| Debt-to-Equity Ratio | 0.10 | 0.13 | 0.08 | 0.11 | 0.13 |
| Debt-to-Capital Ratio | 0.09 | 0.12 | 0.07 | 0.10 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.03 | 0.04 | 0.06 | 0.08 |
| Financial Leverage Ratio | 1.19 | 1.25 | 1.17 | 1.26 | 1.27 |
| Debt Service Coverage Ratio | 6.32 | 4.28 | 2.63 | 5.13 | 3.18 |
| Interest Coverage Ratio | 61.74 | 53.09 | 48.97 | 208.02 | 76.48 |
| Debt to Market Cap | 0.02 | 0.02 | 0.04 | 0.03 | 0.02 |
| Interest Debt Per Share | 1.82 | 2.40 | 1.53 | 1.93 | 1.64 |
| Net Debt to EBITDA | -2.17 | -2.29 | -5.37 | -1.96 | -3.52 |
| Profitability Margins | |||||
| Gross Profit Margin | 50.37% | 48.21% | 46.46% | 56.54% | 44.71% |
| EBIT Margin | 19.07% | 18.30% | 11.41% | 29.77% | 13.90% |
| EBITDA Margin | 24.55% | 23.29% | 16.03% | 33.35% | 18.19% |
| Operating Profit Margin | 17.03% | 16.54% | 9.32% | 28.81% | 12.44% |
| Pretax Profit Margin | 18.80% | 17.98% | 11.22% | 29.63% | 13.74% |
| Net Profit Margin | 14.90% | 13.54% | 8.95% | 23.88% | 10.32% |
| Continuous Operations Profit Margin | 14.90% | 13.54% | 8.95% | 23.88% | 10.32% |
| Net Income Per EBT | 79.25% | 75.28% | 79.71% | 80.58% | 75.14% |
| EBT Per EBIT | 110.34% | 108.72% | 120.38% | 102.83% | 110.45% |
| Return on Assets (ROA) | 8.55% | 8.19% | 4.81% | 16.61% | 7.09% |
| Return on Equity (ROE) | 10.20% | 10.22% | 5.61% | 21.01% | 8.99% |
| Return on Capital Employed (ROCE) | 10.89% | 11.38% | 5.59% | 23.88% | 9.96% |
| Return on Invested Capital (ROIC) | 8.43% | 8.28% | 4.32% | 18.40% | 7.19% |
| Return on Tangible Assets | 8.55% | 8.19% | 4.81% | 16.62% | 7.09% |
| Earnings Yield | 4.24% | 4.10% | 2.66% | 5.57% | 1.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 16.60 | 15.65 | 11.47 | 18.02 | 15.19 |
| Payables Turnover | 56.67 | 40.37 | 43.09 | 33.48 | 163.52 |
| Inventory Turnover | 1.82 | 2.71 | 2.15 | 2.46 | 3.89 |
| Fixed Asset Turnover | 1.48 | 1.64 | 2.38 | 3.01 | 2.52 |
| Asset Turnover | 0.57 | 0.60 | 0.54 | 0.70 | 0.69 |
| Working Capital Turnover Ratio | 1.20 | 1.11 | 0.88 | 1.31 | 1.17 |
| Cash Conversion Cycle | 216.14 | 148.89 | 192.86 | 157.62 | 115.66 |
| Days of Sales Outstanding | 21.99 | 23.33 | 31.82 | 20.26 | 24.04 |
| Days of Inventory Outstanding | 200.59 | 134.61 | 169.50 | 148.27 | 93.86 |
| Days of Payables Outstanding | 6.44 | 9.04 | 8.47 | 10.90 | 2.23 |
| Operating Cycle | 222.58 | 157.94 | 201.33 | 168.53 | 117.89 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.54 | 2.64 | -0.08 | 4.27 | 1.81 |
| Free Cash Flow Per Share | -0.36 | -0.35 | -0.71 | 3.82 | 1.57 |
| Dividend Paid and CapEx Coverage Ratio | 0.54 | 0.67 | -0.02 | 2.95 | 7.55 |
| Capital Expenditure Coverage Ratio | 0.81 | 0.88 | -0.13 | 9.52 | 7.55 |
| Operating Cash Flow Coverage Ratio | 0.86 | 1.12 | -0.06 | 2.24 | 1.11 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.20 | -0.01 | 0.28 | 0.17 |
| Free Cash Flow Yield | -0.82% | -0.79% | -1.71% | 5.87% | 2.41% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 23.59 | 24.39 | 42.95 | 17.95 | 58.69 |
| Price-to-Sales (P/S) Ratio | 3.51 | 3.30 | 3.37 | 4.29 | 6.08 |
| Price-to-Book (P/B) Ratio | 2.41 | 2.49 | 2.11 | 3.77 | 5.29 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -122.68 | -125.88 | -58.45 | 17.04 | 41.57 |
| Price-to-Operating Cash Flow Ratio | 28.98 | 16.66 | -494.36 | 15.25 | 36.07 |
| Price-to-Earnings Growth (PEG) Ratio | 4.72 | 0.28 | -0.58 | 0.08 | -4.02 |
| Enterprise Value Multiple | 12.14 | 11.91 | 15.63 | 10.90 | 29.89 |
| Enterprise Value | 1.20B | 1.07B | 767.13M | 1.38B | 1.73B |
| EV to EBITDA | 12.14 | 11.91 | 15.63 | 10.90 | 29.89 |
| EV to Sales | 2.98 | 2.77 | 2.51 | 3.64 | 5.44 |
| EV to Free Cash Flow | -104.06 | -105.60 | -43.50 | 14.44 | 37.19 |
| EV to Operating Cash Flow | 24.58 | 13.97 | -367.93 | 12.93 | 32.27 |
| Tangible Book Value Per Share | 18.52 | 17.60 | 19.54 | 17.26 | 12.31 |
| Shareholders’ Equity Per Share | 18.52 | 17.60 | 19.55 | 17.26 | 12.31 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.25 | 0.20 | 0.19 | 0.25 |
| Revenue Per Share | 12.69 | 13.28 | 12.25 | 15.19 | 10.72 |
| Net Income Per Share | 1.89 | 1.80 | 1.10 | 3.63 | 1.11 |
| Tax Burden | 0.79 | 0.75 | 0.80 | 0.81 | 0.75 |
| Interest Burden | 0.99 | 0.98 | 0.98 | 1.00 | 0.99 |
| Research & Development to Revenue | 0.06 | 0.06 | 0.11 | 0.07 | 0.08 |
| SG&A to Revenue | 0.28 | 0.26 | 0.26 | 0.21 | 0.24 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.65 | 1.10 | -0.06 | 0.95 | 1.23 |
Currency in TWD
